Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;186(2):273-283.
doi: 10.1007/s10549-020-06092-5. Epub 2021 Jan 21.

Body composition and breast cancer risk and treatment: mechanisms and impact

Affiliations
Review

Body composition and breast cancer risk and treatment: mechanisms and impact

Toshiaki Iwase et al. Breast Cancer Res Treat. 2021 Apr.

Abstract

Purpose: The purpose of this review is to clarify the association of body composition with breast cancer risk and treatment, including physiological mechanisms, and to elucidate strategies for overcoming unfavorable body composition changes that relate to breast cancer progression.

Methods: We have summarized updated knowledge regarding the mechanism of the negative association of altered body composition with breast cancer risk and treatment. We also review strategies for reversing unfavorable body composition based on the latest clinical trial results.

Results: Body composition changes in patients with breast cancer typically occur during menopause or as a result of chemotherapy or endocrine therapy. Dysfunction of visceral adipose tissue (VAT) in the setting of obesity underlies insulin resistance and chronic inflammation, which can lead to breast cancer development and progression. Insulin resistance and chronic inflammation are also observed in patients with breast cancer who have sarcopenia or sarcopenic obesity. Nutritional support and a personalized exercise program are the fundamental interventions for reversing unfavorable body composition. Other interventions that have been explored in specific situations include metformin, testosterone, emerging agents that directly target the adipocyte microenvironment, and bariatric surgery.

Conclusions: A better understanding of the biology of body composition phenotypes is key to determining the best intervention program for patients with breast cancer.

Keywords: Body composition; Breast neoplasm; Obesity; Sarcopenia; Skeletal muscle; Visceral adipose tissue.

PubMed Disclaimer

References

    1. Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM (2017) Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin 67(5):378–397. https://doi.org/10.3322/caac.21405 - DOI - PubMed - PMC
    1. Statistics NCfH (2020) FastStats disability and risk factors-obesity and overweight. https://www.cdc.gov/nchs/fastats/obesity-overweight.htm
    1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315(21):2284–2291. https://doi.org/10.1001/jama.2016.6458 - DOI - PubMed
    1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England) 371(9612):569–578. https://doi.org/10.1016/s0140-6736(08)60269-x - DOI
    1. Fontanella C, Lederer B, Gade S, Vanoppen M, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Gerber B, Hanusch C, Hilfrich J, Huober J, Schneeweiss A, Paepke S, Jackisch C, Mehta K, Nekljudova V, Untch M, Neven P, von Minckwitz G, Loibl S (2015) Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast Cancer Res Treat 150(1):127–139. https://doi.org/10.1007/s10549-015-3287-5 - DOI - PubMed

LinkOut - more resources